STATISTICAL CRITERIA FOR SELECTING QUALITY-CONTROL LIMITS FOR BROTH MICRODILUTION SUSCEPTIBILITY TESTS WITH 39 DIFFERENT ANTIMICROBIAL AGENTS

被引：30
作者：
BARRY, AL [1 ]
FUCHS, PC [1 ]
JONES, RN [1 ]
机构：
[1] ST VINCENT HOSP & MED CTR,PORTLAND,OR
来源：
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE | 1989年 / 12卷 / 05期
关键词：
D O I：
10.1016/0732-8893(89)90112-0
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：413 / 420
页数：8
相关论文
共 15 条
[1]   QUALITY-CONTROL LIMITS FOR MICRODILUTION SUSCEPTIBILITY TESTS WITH NORFLOXACIN [J].
BARRY, AL ;
GAVAN, TL ;
AYERS, LW ;
FUCHS, PC ;
GERLACH, EH ;
THORNSBERRY, C .
JOURNAL OF CLINICAL MICROBIOLOGY, 1987, 25 (01) :165-166
[2]   QUALITY-CONTROL LIMITS FOR MICRODILUTION SUSCEPTIBILITY TESTS WITH AZTREONAM, IMIPENEM, CEFTRIAXONE, CEFTAZIDIME, CEFTIZOXIME, CEFUROXIME, AND CEFONICID [J].
BARRY, AL ;
GAVAN, TL ;
JONES, RN ;
AYERS, LW ;
FUCHS, PC ;
GERLACH, EH ;
THORNSBERRY, C .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1987, 7 (01) :83-87
[3]   QUALITY-CONTROL LIMITS FOR THE STANDARD ANAEROBIC REFERENCE AGAR DILUTION SUSCEPTIBILITY TEST PROCEDURE OF THE NATIONAL COMMITTEE FOR CLINICAL LABORATORY STANDARDS [J].
BARRY, AL ;
FUCHS, PC ;
ALLEN, SD ;
THORNSBERRY, C ;
GERLACH, EH ;
JONES, RN .
JOURNAL OF CLINICAL MICROBIOLOGY, 1989, 27 (01) :192-195
[4]   CRITERIA FOR DISK SUSCEPTIBILITY TESTS AND QUALITY-CONTROL GUIDELINES FOR THE CEFOPERAZONE-SULBACTAM COMBINATION [J].
BARRY, AL ;
JONES, RN .
JOURNAL OF CLINICAL MICROBIOLOGY, 1988, 26 (01) :13-17
[5]   INVITRO ACTIVITY OF FCE-22101, IMIPENEM, AND CEFTAZIDIME AGAINST OVER 6,000 BACTERIAL ISOLATES AND MIC QUALITY-CONTROL LIMITS OF FCE-22101 [J].
BARRY, AL ;
ALDRIDGE, KE ;
ALLEN, SD ;
FUCHS, PC ;
GERLACH, EH ;
JONES, RN ;
PFALLER, MA .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1988, 7 (06) :794-798
[6]   QUALITY-CONTROL LIMITS FOR TEICOPLANIN SUSCEPTIBILITY TESTS AND CONFIRMATION OF DISK DIFFUSION INTERPRETIVE CRITERIA [J].
BARRY, AL ;
JONES, RN ;
GAVAN, TL ;
THORNSBERRY, C .
JOURNAL OF CLINICAL MICROBIOLOGY, 1987, 25 (09) :1812-1814
[7]   OFLOXACIN SUSCEPTIBILITY TESTING QUALITY-CONTROL PARAMETERS FOR MICRODILUTION AND DISK DIFFUSION, AND CONFIRMATION OF DISK DIFFUSION INTERPRETIVE CRITERIA [J].
FUCHS, PC ;
JONES, RN ;
BARRY, AL ;
GAVAN, TL .
JOURNAL OF CLINICAL MICROBIOLOGY, 1989, 27 (01) :49-52
[8]   INVITRO ANTIMICROBIAL ACTIVITY OF TIGEMONAM, A NEW ORALLY-ADMINISTERED MONOBACTAM [J].
FUCHS, PC ;
JONES, RN ;
BARRY, AL .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1988, 32 (03) :346-349
[9]   SUSCEPTIBILITY TESTING OF CARUMONAM - INTERPRETIVE CRITERIA FOR 30-MU-G DISK TESTS AND QUALITY-CONTROL GUIDELINES FOR DISK DIFFUSION AND BROTH MICRODILUTION METHODS [J].
JONES, RN ;
BARRY, AL .
JOURNAL OF CLINICAL MICROBIOLOGY, 1987, 25 (11) :2243-2246
[10]   DISK DIFFUSION SUSCEPTIBILITY TESTING AND BROTH MICRODILUTION QUALITY-CONTROL GUIDELINES FOR BMY-28100, A NEW ORALLY-ADMINISTERED CEPHALOSPORIN [J].
JONES, RN ;
BARRY, AL .
JOURNAL OF CLINICAL MICROBIOLOGY, 1987, 25 (11) :2211-2213
12